Please login to the form below

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market


Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led by established 1st generation tyrosine kinase inhibitors (TKIs). There were several scenarios that the client wanted to test, including impact of launch order and the impact of future 3rd generation TKIs on the drug’s market potential. The research was complicated by the fact that both the clients (and likely key future competitors’), profile was as yet unknown – the research therefore needed to assess likely share while taking account of multiple moving parts...

Read the full case study: 
https://bit.ly/2GG0jh2


29th March 2018

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

News:
Senior Analytics Specialist joins Research Partnership
Research Partnership
Article:
All change – how untangling human behaviour can encourage better health
Research Partnership
Webinar:
Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy
Research Partnership
News:
Therapy Watch COVID-19 tracker
Research Partnership
Events:
Patient Centricity and Engagement Conference 2021
Research Partnership
Webcast:
UX beyond the website: Insights for the age of omnichannel
Research Partnership